ABSTRACT
The clinical workup during the pre-surgical evaluation for epilepsy relies on the electrophysiological recording of spontaneous seizures. The interval until first seizure occurrence is characterized by an increase in seizure likelihood caused by progressive drug dose decreases, during which the epileptic brain transitions from a state of low to a state of high seizure likelihood, so-called pro-ictal state. This study aimed to identify the dynamic brain changes characteristic of this transition from 386 ten-minute segments of intracranial EEG recordings of 29 patients with drug-refractory temporal lobe epilepsy, explored by stereoelectroencephalography, irregularly sampled between electrode implantation and first seizure. As measures of brain dynamics we studied mean phase coherence and relative power in the gamma frequency band, and autocorrelation function width. We further investigate the interaction of those brain dynamics with various susceptibility factors, such as the rate of interictal spikes and high frequency oscillations, circadian and multi-day cycles, and clinical outcomes. We observed a significant increase in relative gamma power in the epileptogenic zone, and an increase in critical slowing in both the epileptogenic zone as well as in presumably healthy cortex. These brain dynamic changes were linked with increases in spike and high frequency oscillations rate. While brain dynamic changes occurred on the slow time scale - from the beginning to the end of the multi-day interval - they did not change in the short-term during the pre-ictal interval. We thus highlight gamma power and critical slowing indices as markers of pro-ictal (as opposed to pre-ictal) brain states, as well as their potential to track the seizure-related brain mechanisms during the presurgical evaluation of epilepsy patients.
Key Points
We investigated the multi-day changes in brain dynamics during presurgical evaluation of patients with drug-resistant temporal lobe epilepsy, inside the epileptogenic zone as well as in healthy brain tissue.
This time interval of increasing seizure susceptibility is marked by increases in gamma band power in the epileptogenic zone and network-wide increase in critical slowing.
The identified multi-day changes were consistently linked to the changes in spikes and high-frequency oscillations (HFOs), while not to other factors like drug dose and circadian time.
While gamma power and critical slowing changed on the scale of days, there was no significant increase in the minutes before seizures, suggesting the brain dynamic changes during presurgical evaluation are likely a multi-day phenomenon associated with pro-ictal states.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the bilateral Barrande Mobility scheme, funded by the Ministry of Education, Youth and Sports of Czech Republic, project number MSMT-7125/2020-16 8J20FR037 and Campus France grant No. 44815QG, the Czech Science Foundation. project No. 21-32608S, by ERDF-Project Brain dynamics, No. CZ.02.01.01/00/22_008/0004643, and the long-term strategic development financing of the Institute of Computer Science (RVO:67985807) of the Czech Academy of Sciences.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Toulouse University Hospital (Research and Innovation Department) gave ethical approval for this work (RnIPH 2020-130).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data available on request due to privacy/ethical restrictions.
